INVO Bioscience Appoints Andrea Goren as Chief Financial Officer

Jun 15, 2021 | Press Releases

SARASOTA, Fla., June 15, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients...

INVO Bioscience Reports First Quarter 2021 Financial and Operating Results and Provides Business Update

May 17, 2021 | Press Releases

Company to Host Conference Call Today at 4:30pm ET (Details Below)SARASOTA, Fla., May 17, 2021 — INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of...

INVO Bioscience to Report First Quarter 2021 Financial Results on Monday, May 17, 2021

May 11, 2021 | Press Releases

Financial results to be released after market close; Conference call to be conducted at 4:30 pm ETSARASOTA, Fla., May 11, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo...

INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for Global Brand Expansion

May 10, 2021 | Press Releases

Aggressive go-to-market sales, partnerships, and marketing strategy to bring INVOcell, fertility care that is accessible, inclusive, and affordable to the more than 90% of couples in need of fertility treatment that currently go without care.SARASOTA, Fla., May 10,...

INVO Bioscience Announces Appointment of Rebecca Messina to the Board of Directors

Apr 26, 2021 | Press Releases

Current Senior Advisor at McKinsey & Co. with strong expertise in global marketing and brand buildingSARASOTA, Fla., April 26, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in...